(2025). Correction to “Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long‐Term Outcome”. Wiley. https://doi.org/10.1002/jmd2.70049
Chicago Style (17th ed.) CitationCorrection to “Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long‐Term Outcome”. Wiley, 2025. https://doi.org/10.1002/jmd2.70049.
MLA (9th ed.) CitationCorrection to “Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long‐Term Outcome”. Wiley, 2025. https://doi.org/10.1002/jmd2.70049.
Warning: These citations may not always be 100% accurate.